mortality/aging
• homozygous null embryos died by E10.5
|
cardiovascular system
N |
• although extraembryonic vascularization was defective, the mutant heart, dorsal aorta and intersomitic vessels appeared normal
|
• homozygous null embryos displayed defective angiogenesis of the yolk sac and branchial arches
|
• other mutant yolk sacs lacked large vitelline blood vessels and had enlarged capillaries instead
|
• in some mutant yolk sacs, there were fewer capillaries and these appeared to be fused with one another generating an abnormal vascular plexus
|
cellular
N |
• mutant ES cells failed to activate genes that normally respond to low oxygen tension (hypoxia)
(J:39730)
• mutant ES cells failed to respond to a decrease in glucose concentration (hypoglycemia)
(J:39730)
• aggregation of mutant ES cells with tetraploid wild-type embryos rescued their placental defects; however, these embryos still died from yolk sac vascular and cardiac defects (reduced endocardial cushions, a hypoplastic ventricular myocardium, an enlarged atrioventricular canal, and distended dorsal aortae)
(J:66515)
|
embryo
• other mutant yolk sacs lacked large vitelline blood vessels and had enlarged capillaries instead
|
• at E9.5, mutant embryos appeared developmentally stunted
• notably, individual organ systems appeared morphologically normal relative to wild-type
|
• at E9.5, mutant embryos appeared smaller and generally wasted
|
• although mutant endothelial cells entered the allantois and chorioallantoic fusion took place, mutant fetal blood vessels failed to invade the chorionic plate by E9.5
|
• complete loss of the labyrinthine layer resulted in decreased exchange between maternal and fetal circulations and subsequent intrauterine growth retardation
|
• mutant placentas showed poor trophoblast invasion of maternal myometrium, similar to preeclamptic human placentas
|
• at E9.5, mutant placentas showed a severe reduction in diploid spongiotrophoblast cell numbers and a significant expansion in the giant cell population
• at E8.5, mutant placentas showed normal numbers of spongiotrophoblast cells that disappeared by E9.5 with no increase in TUNEL+ apoptotic cells, suggesting that spongiotrophoblasts themselves differentiated into giant cells at increased rates
• in contrast to wild-type, homozygous null trophoblast stem (TS) cells cultured under low oxygen tension failed to generate spongiotrophoblasts in vitro
|
• at E9.5, mutant placentas showed a severe reduction in diploid spongiotrophoblast cell numbers and a significant expansion in the giant cell population
• at E8.5, mutant placentas showed normal numbers of spongiotrophoblast cells that disappeared by E9.5 with no increase in TUNEL+ apoptotic cells, suggesting that spongiotrophoblasts themselves differentiated into giant cells at increased rates
|
• at E9.5, many mutant yolk sacs contained normal blood islands but lacked normal vasculature
• mutant yolk sacs contained a reduced number of surrounding smooth muscle cells in vitelline vessels
|
• in some mutant yolk sacs, there were fewer capillaries and these appeared to be fused with one another generating an abnormal vascular plexus
|
• mutant placentas contained no fetal vessels and were significantly smaller relative to wild-type
|
growth/size/body
• at E9.5, mutant embryos appeared developmentally stunted
• notably, individual organ systems appeared morphologically normal relative to wild-type
|
• at E9.5, mutant embryos appeared smaller and generally wasted
|
hematopoietic system
• as early as E8.5, mutant embryos showed a significant decrease in the number of yolk sac hematopoietic progenitors
• this defect appeared to be cell extrinsic as homozygous null ES cells contributed competitively to all hematopoietic lineages in chimeric mice; also, the defect was associated with a reduction in ARNT-dependent VEGFA expression, and was reversed by exogenous VEGFA
|